ORGO

NASDAQ

Organogenesis Holdings Inc.

$2.57+0.22(+9.36%)Mkt Cap: $330.61M

Key Stats

Market Cap

$330.61M

P/E Ratio

17.13

EPS

$0.15

Dividend Yield

0.00%

52-Week Range

$2.21 — $7.08

Volume

2.72M

Avg Volume

1.24M

Beta

1.48

Price Alerts for ORGO

Get alerted when ORGO hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

17.13

Forward P/E

PEG Ratio

0.04

P/S (TTM)

0.51

P/B (TTM)

0.66

P/FCF

EV/EBITDA

EV/Sales

Financial Health

ROE (TTM)

0.10%

ROA (TTM)

0.06%

ROIC

Gross Margin

0.74%

Operating Margin

0.08%

Net Margin

Debt/Equity

0.31

Current Ratio

3.62

Growth

EPS Growth (YoY)

Revenue Growth (YoY)

EPS Growth (3Y)

-0.78%

EPS Growth (5Y)

+0.52%

Sales Growth (3Y)

+0.01%

Sales Growth (5Y)

+0.14%

EPS Est (This Year)

$-0.17

EPS Est (Next Year)

$0.29

Dividends

Dividend Yield

Annual Dividend

Payout Ratio

Frequency

Ex-Dividend Date

Cash/Share

$0.74

Analyst Consensus

Ownership

Institutional %

2.30%

Inst. Net Change

-3409882

Insider Net Shares (90d)

0

Outstanding Shares

128.64M

Float

57.98M

Free Float %

45.07%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2017-01-05

Employees

869

CEO

Gary S. Gillheeney

Index Membership

Website

https://organogenesis.com

Organogenesis Holdings Inc. (ORGO) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $330.61M, a P/E ratio of 17.13, ORGO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ORGO against other stocks using dozens of fundamental and technical filters.

Similar Stocks

Frequently Asked Questions

What is Organogenesis Holdings Inc.'s P/E ratio?

Organogenesis Holdings Inc. (ORGO) has a trailing twelve-month (TTM) P/E ratio of 17.13. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Organogenesis Holdings Inc. pay a dividend?

No, Organogenesis Holdings Inc. (ORGO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Organogenesis Holdings Inc.'s market cap?

Organogenesis Holdings Inc. (ORGO) has a market capitalization of $330.61 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.